Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
78.79
-9.26 (-10.52%)
At close: Aug 12, 2026, 4:00 PM EDT
79.11
+0.32 (0.41%)
After-hours: Aug 12, 2026, 7:58 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $7.05 billion as of August 12, 2026. Its market cap has increased by 289.14% in one year.
Market Cap
7.05B
Enterprise Value
6.95B
1-Year Change
289.14%
Ranking
Category
Stock Price
$78.79
ChartMarket Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.80M to $7.05B, an increase of 4,102.86%. That is a compound annual growth rate of 59.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 7.05B | 135.04% |
| Dec 31, 2025 | 3.00B | 201.47% |
| Dec 31, 2024 | 995.30M | 27.47% |
| Dec 29, 2023 | 780.80M | 90.07% |
| Dec 30, 2022 | 410.80M | 62.31% |
| Dec 31, 2021 | 253.10M | 127.20% |
| Dec 31, 2020 | 111.40M | 39.60% |
| Dec 31, 2019 | 79.80M | -76.20% |
| Dec 31, 2018 | 335.30M | 99.82% |
| Jul 26, 2018 | 167.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 15.94B |
| Elanco Animal Health | 11.03B |
| Dr. Reddy's Laboratories | 10.47B |
| Alkermes | 8.41B |
| Hims & Hers Health | 7.17B |
| Lantheus Holdings | 6.58B |
| Kiniksa Pharmaceuticals International, | 6.09B |
| Amneal Pharmaceuticals | 5.55B |